Terns Pharmaceuticals, Inc. Common Stock

TERN US8808811074

💰
Capitalization
Small-cap

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

🔗
Website
https://www.ternspharma.com
Annual Performance 1
2021 2022 2023 2024 2025
-62% 52% -26% -15% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
37
🙍
Insiders
9
Person Price Shares Total Published Completed
Kuriakose Emil
SR OFF 		7.85
USD 		944
Sold 		7,407
USD 		01/10/2025 01/10/2025
Kuriakose Emil
CMO 		4.27
USD 		853
Sold 		3,640
USD 		01/07/2025 01/07/2025
Kuriakose Emil
CMO 		4.27
USD 		853
Sold 		3,640
USD 		01/07/2025 01/07/2025
Gengos Andrew
CFO 		3.93
USD 		5,000
Bought 		19,650
USD 		27/06/2025 27/06/2025
Gengos Andrew
CFO 		3.93
USD 		5,000
Bought 		19,634
USD 		27/06/2025 27/06/2025
Burroughs Amy L.
CEO 		3.87
USD 		23,314
Bought 		90,230
USD 		25/06/2025 25/06/2025
Gengos Andrew
CFO 		3.95
USD 		5,000
Bought 		19,733
USD 		13/06/2025 16/06/2025
Gengos Andrew
CFO 		3.72
USD 		5,000
Bought 		18,600
USD 		13/06/2025 13/06/2025
Gengos Andrew
CFO 		3.75
USD 		5,000
Bought 		18,750
USD 		13/06/2025 13/06/2025
Kuriakose Emil
CMO 		2.49
USD 		952
Sold 		2,366
USD 		01/04/2025 01/04/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Terns Pharmaceuticals, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-25% -37% -23% -53% 0% 0% -70%
Last 52W Low 52W High All-Time Low All-Time High β
7.99 2.00 8.43 1.50 27.25
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Lu Hongbo 2 4,999,995.00 2,499,997.50 12/09/2024 12/09/2024
Gordon Carl L 6 561,640.00 93,606.67 15/07/2024 16/07/2024
Quigley Jill M. 7 520,050.36 74,292.91 15/07/2024 06/01/2025
Vignola Mark J. 6 254,376.13 42,396.02 30/11/2023 06/01/2025
Burroughs Amy L. 3 203,303.44 67,767.81 30/11/2024 25/06/2025
Gengos Andrew 5 96,365.50 19,273.10 13/06/2025 27/06/2025
Kuriakose Emil 5 42,659.62 8,531.92 02/01/2025 01/10/2025
Yoon Seokho Bryan 2 24,080.58 12,040.29 30/11/2023 31/05/2024
Jung Melita Sun 1 11,497.50 11,497.50 30/11/2024 30/11/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.